INDOLIN-2-ONE DERIVATIVES AS PROTEIN KINASE INHIBITORS
申请人:ANNJI PHARMACEUTICAL CO., LTD.
公开号:US20130281451A1
公开(公告)日:2013-10-24
A novel class of indoline-2-one derivatives are disclosed. These compounds are protein kinase inhibitors which are useful for treating hyperproliferative diseases such as cancer.